Published guidance, NICE advice and quality standards | Guidance

Showing 221 to 230 of 302

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated	TA377	27 January 2016	27 January 2016
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy	TA378	27 January 2016	27 January 2016
Bladder cancer	QS106	17 December 2015	17 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions	DG19	11 November 2015	11 November 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer	IPG532	23 September 2015	23 September 2015
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015
Preoperative high dose rate brachytherapy for rectal cancer	IPG531	26 August 2015	26 August 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	TA347	22 July 2015	22 July 2015